News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,711 Results
Type
Article (203)
Company Profile (2)
Press Release (4506)
Section
Business (1406)
Career Advice (3)
Deals (238)
Drug Development (127)
FDA (178)
Job Trends (126)
News (2077)
Policy (152)
Tag
Academia (24)
Alliances (416)
Approvals (180)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (104)
Breast cancer (3)
Cancer (6)
Cardiovascular disease (1)
Career advice (2)
Cell therapy (3)
Clinical research (75)
Collaboration (13)
COVID-19 (4)
C-suite (6)
Data (16)
Diabetes (9)
Diagnostics (10)
Earnings (423)
Events (532)
Executive appointments (8)
FDA (196)
Funding (12)
Government (13)
Guidances (5)
Healthcare (69)
Infectious disease (6)
Inflammatory bowel disease (1)
Intellectual property (1)
IPO (76)
Job creations (24)
Job search strategy (2)
JPM (1)
Layoffs (1)
Legal (33)
Machine learning (1)
Manufacturing (4)
Medical device (193)
Medtech (193)
Mergers & acquisitions (168)
Metabolic disorders (9)
NextGen: Class of 2026 (41)
Non-profit (18)
Pain (2)
Partnered (1)
Patents (3)
People (467)
Phase 1 (34)
Phase 2 (31)
Phase 3 (17)
Pipeline (30)
Postmarket research (3)
Preclinical (53)
Rare diseases (1)
Real estate (49)
Regulatory (125)
Reports (2)
Research institute (16)
Series B (1)
Startups (44)
Supply chain (1)
Vaccines (2)
Date
Last 7 days (1)
Last 30 days (13)
Last 365 days (116)
2026 (17)
2025 (111)
2024 (147)
2023 (178)
2022 (348)
2021 (346)
2020 (317)
2019 (251)
2018 (191)
2017 (224)
2016 (292)
2015 (320)
2014 (204)
2013 (182)
2012 (195)
2011 (211)
2010 (209)
Location
Africa (1)
Alabama (8)
Asia (230)
Australia (30)
California (18)
Canada (25)
China (4)
Connecticut (2)
Europe (451)
Florida (8)
Georgia (3)
Illinois (4)
Indiana (1)
Japan (1)
Kansas (2)
Maryland (2)
Massachusetts (35)
Michigan (10)
Minnesota (2)
Mississippi (2)
Nevada (1)
New Jersey (20)
New Mexico (3)
New York (6)
North Carolina (5)
Northern California (6)
Ohio (1)
Pennsylvania (6)
South America (2)
Southern California (11)
Texas (6)
United States (148)
Utah (2)
Virginia (4)
Washington State (1)
4,711 Results for "regentis biomaterials".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
·
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
·
4 min read
Press Releases
Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial
February 5, 2026
·
6 min read
Press Releases
Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC
December 19, 2025
·
6 min read
Press Releases
Regentis’ GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation
January 6, 2026
·
7 min read
Press Releases
Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.
January 29, 2026
·
7 min read
Press Releases
Regentis’ GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method
January 20, 2026
·
7 min read
Press Releases
Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials
January 23, 2026
·
6 min read
Press Releases
Curiteva Proudly Announces the Publication of a Peer-Reviewed Study in the Journal of Biomaterials (JBI)
November 14, 2025
·
3 min read
Press Releases
Kelyniam Global Secures Exclusive U.S. License for Evonik’s VESTAKEEP® Fusion Biomaterial in Cranial Implants
November 14, 2025
·
2 min read
1 of 472
Next
